Regorafenib

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP02105CAS No. ：755037-03-7Purity：98%

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	755037-03-7	Cat. No.	BCP02105
Related Products	1019206-88-2（Regorafenib monohydrate） 835621-07-3（Regorafenib hydrochloride）
Name	Regorafenib
Synonyms	BAY 734506; BAY734506; BAY-734506;BAY 73-4506;BAY73-4506;
SMILES	C12=NC(NC3=CC=C(N4CCOCC4)C=C3)=NC(NC5CCCCC5)=C1NC=N2
Chemical Name
Formula	C21H15ClF4N4O3	M. Wt	482.82
Purity	98%	Storage	Store at 4-8°C
Description	Regorafenib strongly prevents VEGFR2 autophosphorylation in NIH-3T3/VEGFR2 cells with IC50 of 3 nM. In HAoSMCs, regorafenib suppress PDGFR-β autophosphorylation after stimulation with PDGF-BB, with an IC50 of 90 nM. Regorafenib also inhibits FGFR signaling in MCF-7 breast cancer (BC) cells stimulated with FGF10. Regorafenib very potently inhibited the mutant receptors KITK642E and RETC634W, with IC50 of approximately 20 nM and 10 nM, respectively. Regorafenib inhibits the proliferation of VEGF165-stimulated HUVECs, with an IC50 of approximately 3 nM. Regorafenib prevents the proliferation of FGF2-stimulated HUVECs and of PDGF-BB-stimulated HAoSMCs with IC50 of 127 nM and 146 nM, respectively.